Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Jasmin

Showing results (221-230 of 300) with videos related to

Pageof 30
Sort By:
Experimental Hematology|April 1, 1995
In vitro chronopharmacology of recombinant mouse IL-3, mouse GM-CSF, and human G-CSF on murine myeloid progenitor cellsB Perpoint, C Le Bousse-Kerdilès, D Clay, et al.
European Journal of Immunology|July 1, 1995
Non random activation of endogenous interleukin-2, (IL-2), IL-2 receptor alpha and IL-2 receptor beta genes after transfection of mouse fibroblasts with a cDNA for the alpha chain of the human IL-2 receptorD Han, S Plaisance, E Rubinstein, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanomaW Fiedler, C Jasmin, P H De Mulder, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Vindesine: a new vinca alkaloidM Bayssas, J Gouveia, F de Vassal, et al.
La Nouvelle Presse Medicale|June 5, 1976
[Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)]G Mathe, P Pouillart, F De Vassal, et al.
Lancet (London, England)|May 22, 1976
Letter: Remission induction in acute lymphoid and acute myeloid leukaemiasG Mathé, P Pouillart, F De Vassal, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre studyS Negrier, T Philip, G Stoter, et al.
Bulletin Du Cancer|July 1, 1974
[10 years of immunotherapy for acute lymphocytic leukemias. Non-cytologic prognosis factors in acute lymphocytic leukemias]G Mathé, J L Amiel, L Schwarzenberg, et al.
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|June 1, 1970
Remission induction with Poly IC in patients with acute lymphoblastic leukaemia (preliminary results)G Mathé, J L Amiel, L Schwarzenberg, et al.
National Cancer Institute Monograph|December 1, 1973
BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual diseaseG Mathé, R Weiner, P Pouillart, et al.
Pageof 30

Showing results (221-230 of 300) with videos related to

Sort By:
Pageof 30
Experimental Hematology|April 1, 1995
In vitro chronopharmacology of recombinant mouse IL-3, mouse GM-CSF, and human G-CSF on murine myeloid progenitor cellsB Perpoint, C Le Bousse-Kerdilès, D Clay, et al.
European Journal of Immunology|July 1, 1995
Non random activation of endogenous interleukin-2, (IL-2), IL-2 receptor alpha and IL-2 receptor beta genes after transfection of mouse fibroblasts with a cDNA for the alpha chain of the human IL-2 receptorD Han, S Plaisance, E Rubinstein, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanomaW Fiedler, C Jasmin, P H De Mulder, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Vindesine: a new vinca alkaloidM Bayssas, J Gouveia, F de Vassal, et al.
La Nouvelle Presse Medicale|June 5, 1976
[Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)]G Mathe, P Pouillart, F De Vassal, et al.
Lancet (London, England)|May 22, 1976
Letter: Remission induction in acute lymphoid and acute myeloid leukaemiasG Mathé, P Pouillart, F De Vassal, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre studyS Negrier, T Philip, G Stoter, et al.
Bulletin Du Cancer|July 1, 1974
[10 years of immunotherapy for acute lymphocytic leukemias. Non-cytologic prognosis factors in acute lymphocytic leukemias]G Mathé, J L Amiel, L Schwarzenberg, et al.
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|June 1, 1970
Remission induction with Poly IC in patients with acute lymphoblastic leukaemia (preliminary results)G Mathé, J L Amiel, L Schwarzenberg, et al.
National Cancer Institute Monograph|December 1, 1973
BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual diseaseG Mathé, R Weiner, P Pouillart, et al.
Pageof 30